Related Experiment Video
Updated: Jul 2, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum
Meng Dongya1, Xue Wencheng, Ma Xiaobo
1Department of Clinical laboratory, Liao Ning North Hospital, Shenyang, Liaoning, China.
Objective:
To study the mechanisms of acquired resistance of Ureaplasma urealyticum (Uu) to Macrolide antibiotics.
Methods:
Eighteen strains of Uu clinical isolates with different phenotypes of resistance to Macrolide antibiotics were screened for mutations in 23S rRNA in comparison with the reference strain ATCC 27618 and AF272627-1 in GenBank, which is susceptible to Macrolide antibiotics.
Results:
Compared to the sequence of reference strains ATCC 27618 and AF272627-1, three transitions were found in 23S rRNA of Uu clinical isolates with acquired resistance to Macrolide antibiotics. The C2243N (T or C) transition was found in the 23S rRNA sequence of five strains with the phenotype of acquired resistance to Roxithromycin (ROM) and Azithromycin (AZM). The two changes of A2149C and A2181T were found in the 23S rRNA sequence of nine strains with the phenotype of resistance to ROM and midrange resistance to AZM, and they were also found in that of four strains with the phenotype of sensitivity to macrolides (Josamycin, Clarithromycin, ROM, and AZM). No mutation was found in the ATCC 27618.
Conclusion:
The mechanisms of Uu resistance to ROM and AZM may be associated with the C2243N (T or C) mutation in 23S rRNA. Further studies are necessary to confirm this hypothesis.
Insights
Mechanisms of Ureaplasma urealyticum (Uu) acquired resistance to macrolide antibiotics like Roxithromycin and Azithromycin may involve C2243N mutations in 23S rRNA. Further research is needed to confirm these findings in Uu.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Ureaplasma urealyticum (Uu) is a common human pathogen.
- Macrolide antibiotics are frequently used to treat Uu infections.
- Acquired resistance to macrolides in Uu poses a significant clinical challenge.
Purpose of the Study:
- To investigate the molecular mechanisms underlying acquired resistance of Ureaplasma urealyticum to macrolide antibiotics.
- To identify specific mutations in the 23S rRNA gene associated with macrolide resistance in Uu clinical isolates.
Main Methods:
- Analysis of 18 Uu clinical isolates with varying macrolide resistance phenotypes.
- Sequencing of the 23S rRNA gene in Uu isolates and comparison with reference strains (ATCC 27618 and AF272627-1).
- Screening for mutations, specifically transitions, within the 23S rRNA gene.
Main Results:
- Three transitions were identified in the 23S rRNA gene of macrolide-resistant Uu isolates.
- The C2243N (T or C) transition was observed in five strains resistant to Roxithromycin (ROM) and Azithromycin (AZM).
- A2149C and A2181T changes were found in strains resistant to ROM and mid-range resistant to AZM, and also in some macrolide-susceptible strains.
Conclusions:
- The C2243N (T or C) mutation in 23S rRNA is a potential mechanism for acquired resistance in Uu to ROM and AZM.
- Further studies are required to definitively confirm the role of this mutation in Uu macrolide resistance.
- Understanding these resistance mechanisms is crucial for guiding antimicrobial therapy choices.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Mutations in Microorganisms
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Viral Mutations
Development of Antibiotic Resistance
